0.09 per_100000The incidence of confirmed COVID-19 cases in Nigeria ranged from 0.09 per 100,000 in Kogi to 83.7 per 100,000 in Lagos.
NigeriaCOVID-19published 2020The Pan African medical journalPubMeddocument of 6 observations
Gold tier: mechanically validated evidence, with its primary source.
8,823 evidence items · page 64 / 353
0.09 per_100000The incidence of confirmed COVID-19 cases in Nigeria ranged from 0.09 per 100,000 in Kogi to 83.7 per 100,000 in Lagos.
NigeriaCOVID-19published 2020The Pan African medical journalPubMeddocument of 6 observations
7 %EGFR amplification was found in 7% of breast cancer patients in the study.
Nigeriacancer du seinpublished 2026Cancer geneticsPubMeddocument of 4 observations
33 monthsThe non-parametric median survival time of TB patients co-infected with HIV was 33 months.
Nigeriatuberculose · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations
62.52 %Approximately 62.52% of very high malaria incidence zones coincide with high and very high vulnerability areas.
Nigeriapaludismepublished 2026Health & placePubMeddocument of 2 observations
70 %Vitamin D deficiency was present in 70.0% of ART-experienced participants.
Nigeriavitamin D deficiencypublished 2023West African journal of medicinePubMeddocument of 10 observations
Creatinine clearance was significantly lower during the acute illness than after recovery from falciparum malaria in 40 children.
Nigeriapaludismepublished 1996Archives of disease in childhoodeurope_pmcdocument of 10 observations
75.9 %The frequency of cognitive impairment among CART-exposed patients was 75.9% (41 out of 54 patients).
NigeriaVIH/sidapublished 2026Annals of African medicinePubMeddocument of 7 observations
54.3 %54.3% of the men were considered 'involved' in their female partners' screening for breast and cervical cancers.
Nigeriabreast and cervical cancersobserved 2018published 2023PloS onePubMeddocument of 14 observations
6 countriesAs of 05 September 2024, six countries are experiencing sustained human-to-human transmission of mpox: DRC, Burundi, Nigeria, South Africa, Cote d’Ivoire, and Central African Republic.
Afrique du Sud · Burundi · Nigeria · RDCmpoxobserved 05 September 2024Africa CDCdocument of 48 observations
400 mg/kgAt a dose of 400 mg/kg, Triumfetta cordifolia significantly suppressed parasitemia in a mouse model of established P. berghei ANKA-infection.
Nigeriapaludismepublished 2020Journal of ethnopharmacologyPubMeddocument of 3 observations
3.1 %Two (3.1%) of the 65 patients with MTB detection had rifampicin resistance.
Nigeriatuberculosepublished 2025West African journal of medicinePubMeddocument of 7 observations
21.1 %Severe malaria accounted for 21.1% of all malaria cases.
Nigeriapaludismepublished 2022West African journal of medicinePubMeddocument of 6 observations
40.2 %Emotional abuse was reported by 70 respondents (40.2%).
Nigeriaintimate partner violenceobserved 2019published 2023Journal of the International Association of Providers of AIDS CarePubMeddocument of 6 observations
47.8 %Severe anaemia was more common among under-fives (47.8%).
Nigeriaanémieobserved 2019–2022published 2024Ghana medical journalPubMeddocument of 10 observations
27.78 per_100_person_yearsIncidence of mortality showed a reducing trend and ranged from 27.78 per 100 person-years in 2020 to 0.81 per 100 person-years in 2022.
NigeriaVIH/sidaobserved 2020published 2025PloS onePubMeddocument of 8 observations
95 %The HIV testing coverage among adolescents and young adults (AYA) in Nigeria is well below the national target of 95% indicated in the national HIV/AIDS strategic framework (2017–2021).
NigeriaVIH/sidaobserved 2017-2021published 2020PloS onePubMeddocument of 4 observations
69.4 %Primary prevention of HIV (PPV) had the highest 'yes' willingness to pay (WTP) response of 152 (69.4%).
NigeriaVIH/sidapublished 2021Journal of clinical pharmacy and therapeuticsPubMeddocument of 5 observations
0 %CAE had a specificity of 0% for identifying the AC genotype relative to PCR.
Nigeriadrépanocytosepublished 2021Global pediatric healtheurope_pmcdocument of 5 observations
14.6 %Only 14.6% of the female secondary school teachers in Enugu metropolis had taught their students about cervical cancer or HPV vaccines.
Nigeriacancer du col de l'utérusobserved 2017published 2021The Pan African medical journalPubMeddocument of 7 observations
12.2 %Only 96 (12.2%) of the 780 mothers were aware of comprehensive care for babies with sickle cell disease.
Nigeriadrépanocytosepublished 2023West African journal of medicinePubMeddocument of 5 observations
93.7 %Fine needle aspiration cytology achieved a specificity of 93.7% for breast lumps in this study.
Nigeriabreast lumpspublished 2021Nigerian journal of clinical practicePubMeddocument of 13 observations
2.34 AORGestational age above 20 weeks was a determinant of asymptomatic bacteriuria in HIV-negative women with adjusted odds ratio 2.34.
Nigeriaasymptomatic bacteriuriaobserved October 2017 to March 2018published 2020West African journal of medicinePubMeddocument of 5 observations
51 monthsThe non-parametric median survival time of TB patients was 51 months.
Nigeriatuberculosepublished 2020PloS onePubMeddocument of 4 observations
69 %The mean diabetes service readiness score was 69%.
Nigeriadiabète (non précisé)published 2026BMC primary carePubMeddocument of 5 observations
50 %Over 50% of global HIV infection and deaths occur in sub-Saharan Africa.
NigeriaVIH/sidapublished 2021Journal of medical virologyPubMeddocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.